Granulomatous-Lymphocytic Interstitial Lung Disease in 22q11.2 Deletion Syndrome: a Case Report and Literature Review
- 146 Downloads
Purpose of Review
Granulomatous-lymphocytic interstitial lung disease (GLILD) has classically been associated with common variable immune deficiency (CVID), but is increasingly being reported in other immunodeficiencies. We describe the second reported case of GLILD in a patient with 22q11.2 deletion syndrome (22q11.2DS) and review the recent literature surrounding GLILD.
GLILD is characterized by granulomata and lymphoproliferation. Consensus statements and retrospective and case-control studies have better elucidated the clinicopathological and radiographic manifestations of GLILD, allowing for its differentiation from similar conditions like sarcoidosis. Gaps of knowledge remain, however, particularly regarding optimal management strategies. Combination therapies targeting T and B cell populations have recently shown favorable results.
GLILD is associated with poorer outcomes in CVID. Its recognition as a rare complication of 22q11.2DS and other immunodeficiencies therefore has important therapeutic and prognostic implications. Additional research is needed to better understand the natural history and pathogenesis of GLILD and to develop evidence-based practice guidelines.
KeywordsGranulomatous-lymphocytic interstitial lung disease 22q11.2 deletion syndrome Common variable immune deficiency Primary immune deficiency Sarcoidosis Autoimmunity
22q11.2 deletion syndrome
Granulomatous-lymphocytic interstitial lung disease
Interstitial lung disease
Common variable immune deficiency
Primary immune deficiency
Fluorescence in situ hybridization
Positron emission tomography computed tomography
Video-assisted thoracoscopic surgery
Diffusion capacity for carbon monoxide
Lymphoid interstitial pneumonia
- BLF/UK PIN
British Lung Foundation and United Kingdom Primary Immunodeficiency Network
Autoimmune hemolytic anemia
Idiopathic thrombocytopenia purpura
United States Immunodeficiency Network
Compliance with Ethical Standards
Conflict of Interest
The authors declare no conflicts of interest relevant to this manuscript.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 2.•• Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol. 2004;114(2):415–21. https://doi.org/10.1016/j.jaci.2004.05.057. First coined the term GLILD in patients with CVID and reported that a diagnosis of GLILD is associated with increased morbidity and early mortality. CrossRefPubMedGoogle Scholar
- 4.Lopez-Herrera G, Tampella G, Pan-Hammarstrom Q, Herholz P, Trujillo-Vargas CM, Phadwal K, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012;90(6):986–1001. https://doi.org/10.1016/j.ajhg.2012.04.015.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Steele CL, Dore M, Ammann S, Loughrey M, Montero A, Burns SO, et al. X-linked inhibitor of apoptosis complicated by granulomatous lymphocytic interstitial lung disease (GLILD) and granulomatous hepatitis. J Clin Immunol. 2016;36(7):733–8. https://doi.org/10.1007/s10875-016-0320-3.CrossRefPubMedGoogle Scholar
- 7.Jensen ML, Bendstrup E, Hilberg O. Granulomatous-lymphocytic interstitial lung disease and recurrent sinopulmonary infections in a patient with Good’s syndrome. BMJ case reports. 2015;2015 https://doi.org/10.1136/bcr-2014-205635.
- 10.• Mather MW, Hayhurst H, Bacon CM, Cole TS, Pan-Hammarstrom Q, Misbah S, et al. Mutation of TNFRSF13B in a child with 22q11 deletion syndrome associated with granulomatous lymphoproliferation. J Allergy Clin Immunol. 2015;135(2):559–61. https://doi.org/10.1016/j.jaci.2014.07.025. The first and only previously published report of GLILD in a patient with 22q11.2DS. CrossRefPubMedGoogle Scholar
- 11.•• Hurst JR, Verma N, Lowe D, Baxendale HE, Jolles S, Kelleher P, et al. British Lung Foundation/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2017;5(4):938–45. https://doi.org/10.1016/j.jaip.2017.01.021. These consensus statements represent the largest collection of shared clinical experience in the multi-disciplinary care of patients with GLILD and are the first step towards development of practice guidelines. CrossRefPubMedGoogle Scholar
- 15.• Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol. 2013;33(1):30–9. https://doi.org/10.1007/s10875-012-9755-3. This retrospective chart review of 7 patients with GLILD that were unresponsive to conventional therapy with corticosteroids demonstrated the utility of combination chemotherapy treatment. CrossRefPubMedGoogle Scholar
- 16.Mannina A, Chung JH, Swigris JJ, Solomon JJ, Huie TJ, Yunt ZX, et al. Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease. Ann Am Thorac Soc. 2016;13(7):1042–9. https://doi.org/10.1513/AnnalsATS.201511-728OC.CrossRefPubMedGoogle Scholar
- 17.Hartono S, Motosue MS, Khan S, Rodriguez V, Iyer VN, Divekar R, et al. Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency. Ann Allergy, Asthma Immunol: Off Publ Am Coll Allergy, Asthma, Immunol. 2017;118(5):614–20. https://doi.org/10.1016/j.anai.2017.01.004.CrossRefGoogle Scholar
- 19.Tanaka N, Kim JS, Bates CA, Brown KK, Cool CD, Newell JD, et al. Lung diseases in patients with common variable immunodeficiency: chest radiographic, and computed tomographic findings. J Comput Assist Tomogr. 2006;30(5):828–38. https://doi.org/10.1097/01.rct.0000228163.08968.26.CrossRefPubMedGoogle Scholar
- 21.Torigian DA, LaRosa DF, Levinson AI, Litzky LA, Miller WT, Jr. Granulomatous-lymphocytic interstitial lung disease associated with common variable immunodeficiency: CT findings. J Thorac Imaging 2008;23(3):162–169. doi: https://doi.org/10.1097/RTI.0b013e318166d32f.
- 22.• Rao N, Mackinnon AC, Routes JM. Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency—histologic and immunohistochemical analyses of 16 cases. Hum Pathol. 2015;46(9):1306–14. https://doi.org/10.1016/j.humpath.2015.05.011. Characterized the spectrum of histopathologic and immunohistochemical features of GLILD through a retrospective chart review of 16 cases and highlighted the absence of FOXP3+ T regulatory cells in lung biopsies of patients with GLILD. CrossRefPubMedPubMedCentralGoogle Scholar
- 24.• Shanks AM, Alluri R, Herriot R, Dempsey O. Misdiagnosis of common variable immune deficiency. BMJ case reports. 2014;2014(apr01 1):bcr2013202806. https://doi.org/10.1136/bcr-2013-202806. This case report emphasized the clinical and histologic overlap of GLILD and sarcoidosis, often leading to misdiagnosis. CrossRefPubMedPubMedCentralGoogle Scholar
- 26.• Bouvry D, Mouthon L, Brillet PY, Kambouchner M, Ducroix JP, Cottin V et al. Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis. Eur Respir J. 2013;41(1):115–22. doi: https://doi.org/10.1183/09031936.00189011. The clinical, radiographic, and histologic features as well as the clinical course of GLILD and sarcoidosis are compared and contrasted in this case-control study.
- 30.Levinson AI, Hopewell PC, Stites DP, Spitler LE, Fudenberg HH. Coexistent lymphoid interstitial pneumonia, pernicious anemia, and agammaglobulinemia. Arch Intern Med. 1976;136(2):213–6. https://doi.org/10.1001/archinte.1976.03630020067014.CrossRefPubMedGoogle Scholar
- 31.Kohler PF, Cook RD, Brown WR, Manguso RL. Common variable hypogammaglobulinemia with T-cell nodular lymphoid interstitial pneumonitis and B-cell nodular lymphoid hyperplasia: different lymphocyte populations with a similar response to prednisone therapy. J Allergy Clin Immunol. 1982;70(4):299–305. https://doi.org/10.1016/0091-6749(82)90066-5.CrossRefPubMedGoogle Scholar
- 32.Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, Vlkova M., Hernandez M., Detkova D., Bos P.R., Poerksen G., von Bernuth H., Baumann U., Goldacker S., Gutenberger S., Schlesier M., Bergeron-van der Cruyssen F., le Garff M., Debre P., Jacobs R., Jones J., Bateman E., Litzman J., van Hagen P.M., Plebani A., Schmidt R.E., Thon V., Quinti I., Espanol T., Webster A.D., Chapel H., Vihinen M., Oksenhendler E., Peter H.H., Warnatz K. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008;111(1):77–85. doi: https://doi.org/10.1182/blood-2007-06-091744, 1.
- 35.Hasegawa M, Sakai F, Okabayashi A, Sato A, Yokohori N, Katsura H, et al. Intravenous immunoglobulin monotherapy for granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency. Intern Med (Tokyo, Japan). 2017;56(21):2899–902. https://doi.org/10.2169/internalmedicine.7757-16. CrossRefGoogle Scholar
- 36.Boursiquot JN, Gerard L, Malphettes M, Fieschi C, Galicier L, Boutboul D, et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol. 2013;33(1):84–95. https://doi.org/10.1007/s10875-012-9778-9.CrossRefPubMedGoogle Scholar
- 41.• Jolles S, Carne E, Brouns M, El-Shanawany T, Williams P, Marshall C, et al. FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). Clin Exp Immunol. 2017;187(1):138–45. https://doi.org/10.1111/cei.12856. This case report suggests that FDG PET-CT imaging may prove to be a useful imaging modality that combines both functional and anatomical information in the long-term monitoring of patients with GLILD. CrossRefPubMedGoogle Scholar
- 42.• Tashtoush B, Memarpour R, Ramirez J, Bejarano P, Mehta J. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency. Clin Respir J. 2016;12(1):337–43. https://doi.org/10.1111/crj.12511. Highlights the need to maintain a high index of suspicion for GLILD as this may be the first manifestation of an underlying immune deficiency. CrossRefPubMedGoogle Scholar